Metastatic genes targeted by an antioxidant in an established radiation- and estrogen-breast cancer model

Calaf,Gloria M.; Roy,Debasish

doi:10.3892/ijo.2017.4125

Metastatic genes targeted by an antioxidant in an established radiation- and estrogen-breast cancer model

Authors:
- Gloria M. Calaf
- Debasish Roy
View Affiliations

Affiliations: Instituto de Alta Investigación, Universidad de Tarapacá, Arica, Chile, Department of Natural Sciences, Hostos College, The City University of New York, Bronx, NY, USA
Published online on: September 14, 2017 https://doi.org/10.3892/ijo.2017.4125
Pages: 1590-1600

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer remains the second most common disease worldwide. Radiotherapy, alone or in combination with chemotherapy, is widely used after surgery as a treatment for cancer with proven therapeutic efficacy manifested by reduced incidence of loco-regional and distant recurrences. However, clinical evidence indicates that relapses occurring after radiotherapy are associated with increased metastatic potential and poor prognosis in the breast. Among the anticarcinogenic and antiproliferative agents, curcumin is a well-known major dietary natural yellow pigment derived from the rhizome of the herb Curcuma longa (Zingiberaceae). The aim of the present study was to analyze the differential expression of metastatic genes in radiation- and estrogen-induced breast cancer cell model and the effect of curcumin on such metastatic genes in breast carcinogenesis. Expression levels of TGF-α and TGFβ1 genes were upregulated in MCF-10F and downregulated in Tumor2 cell lines treated with curcumin. Expression levels of other genes such as caspase 9 and collagen 4 A2 were upregulated in both MCF-10F and Tumor2-treated cell lines. Integrin α5 and cathepsin B and D decreased its expression in Tumor2, whereas E-Cadherin, c-myc and CD44 expressions were only increased in MCF-10F. It can be concluded that metastatic genes can be affected by curcumin in cancer progression and such substance can be used in breast cancer patients with advanced disease without side-effects commonly observed with therapeutic drugs.

View Figures

View References

1	Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and Bray F: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403. 2013. View Article : Google Scholar : PubMed/NCBI
2	Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, et al European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 345:1378–1387. 2001. View Article : Google Scholar
3	Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet. 378:1707–1716. 2011. View Article : Google Scholar : PubMed/NCBI
4	Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S, Gutierrez M, Ali D, et al: Breast cancer with synchronous metastases: Survival impact of exclusive locoregional radiotherapy. J Clin Oncol. 27:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
5	Mattsson A, Rudén BI, Hall P, Wilking N and Rutqvist LE: Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst. 85:1679–1685. 1993. View Article : Google Scholar : PubMed/NCBI
6	Goldstein NS, Kestin L and Vicini F: Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol. 120:500–527. 2003. View Article : Google Scholar : PubMed/NCBI
7	O'Brien CJ, Smith JW, Soong SJ, Urist MM and Maddox WA: Neck dissection with and without radiotherapy: Prognostic factors, patterns of recurrence, and survival. Am J Surg. 152:456–463. 1986. View Article : Google Scholar : PubMed/NCBI
8	Vikram B, Strong EW, Shah JP and Spiro R: Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg. 6:734–737. 1984. View Article : Google Scholar : PubMed/NCBI
9	Barcellos-Hoff MH and Ravani SA: Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60:1254–1260. 2000.PubMed/NCBI
10	Lemay R, Archambault M, Tremblay L, Bujold R, Lepage M and Paquette B: Irradiation of normal mouse tissue increases the invasiveness of mammary cancer cells. Int J Radiat Biol. 87:472–482. 2011. View Article : Google Scholar : PubMed/NCBI
11	Bouchard G, Bouvette G, Therriault H, Bujold R, Saucier C and Paquette B: Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases. Br J Cancer. 109:1829–1838. 2013. View Article : Google Scholar : PubMed/NCBI
12	Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al: Molecular portraits of human breast tumours. Nature. 406:747–752. 2000. View Article : Google Scholar : PubMed/NCBI
13	Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
14	Kozłowski J, Kozłowska A and Kocki J: Breast cancer metastasis - insight into selected molecular mechanisms of the phenomenon. Postepy Hig Med Dosw Online. 69:447–451. 2015. View Article : Google Scholar
15	Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, Foekens JA and Martens JW: Subtypes of breast cancer show preferential site of relapse. Cancer Res. 68:3108–3114. 2008. View Article : Google Scholar : PubMed/NCBI
16	Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL and van't Veer LJ: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA. 100:15901–15905. 2003. View Article : Google Scholar : PubMed/NCBI
17	Klein CA: Gene expression signatures, cancer cell evolution and metastatic progression. Cell Cycle. 3:29–31. 2004. View Article : Google Scholar
18	Sato F, Saji S and Toi M: Genomic tumor evolution of breast cancer. Breast Cancer. 23:4–11. 2016. View Article : Google Scholar
19	Aggarwal BB, Kumar A and Bharti AC: Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 23:363–398. 2003.PubMed/NCBI
20	Korutla L and Kumar R: Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta. 1224:597–600. 1994. View Article : Google Scholar : PubMed/NCBI
21	Surh YJ, Han SS, Keum YS, Seo HJ and Lee SS: Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-kappaB and AP-1. Biofactors. 12:107–112. 2000. View Article : Google Scholar
22	Shiri S, Alizadeh AM, Baradaran B, Farhanghi B, Shanehbandi D, Khodayari S, Khodayari H and Tavassoli A: Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment. Asian Pac J Cancer Prev. 16:3917–3922. 2015. View Article : Google Scholar : PubMed/NCBI
23	Farhangi B, Alizadeh AM, Khodayari H, Khodayari S, Dehghan MJ, Khori V, Heidarzadeh A, Khaniki M, Sadeghiezadeh M and Najafi F: Protective effects of dendrosomal curcumin on an animal metastatic breast tumor. Eur J Pharmacol. 758:188–196. 2015. View Article : Google Scholar : PubMed/NCBI
24	Zong H, Wang F, Fan QX and Wang LX: Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep. 39:4803–4808. 2012. View Article : Google Scholar
25	Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 11:7490–7498. 2005. View Article : Google Scholar : PubMed/NCBI
26	Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol. 69:195–206. 2006.
27	Shishodia S, Amin HM, Lai R and Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 70:700–713. 2005. View Article : Google Scholar : PubMed/NCBI
28	Siwak DR, Shishodia S, Aggarwal BB and Kurzrock R: Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer. 104:879–890. 2005. View Article : Google Scholar : PubMed/NCBI
29	Ramachandran C and You W: Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat. 54:269–278. 1999. View Article : Google Scholar : PubMed/NCBI
30	Zhou QM, Chen QL, Du J, Wang XF, Lu YY, Zhang H and Su SB: Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: A cDNA microarray analysis. Int J Mol Sci. 15:16284–16301. 2014. View Article : Google Scholar : PubMed/NCBI
31	Calaf GM and Hei TK: Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis. 4:769–776. 2000. View Article : Google Scholar
32	Roy D, Calaf G and Hei TK: Profiling of differentially expressed genes induced by high linear energy transfer radiation in breast epithelial cells. Mol Carcinog. 31:192–203. 2001. View Article : Google Scholar : PubMed/NCBI
33	Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation. Int J Radiat Biol. 77:31–40. 2001. View Article : Google Scholar : PubMed/NCBI
34	Calaf GM and Roy D: Gene and protein expressions induced by 17β-estradiol and parathion in cultured breast epithelial cells. Mol Med. 13:255–265. 2007. View Article : Google Scholar : PubMed/NCBI
35	Calaf GM, Roy D and Hei TK: Immunochemical analysis of protein expression in breast epithelial cells transformed by estrogens and high linear energy transfer (LET) radiation. Histochem Cell Biol. 124:261–274. 2005. View Article : Google Scholar : PubMed/NCBI
36	Calaf GM, Alvarado ME and Hei TK: Beta catenin is associated with breast cancer progression in vitro. Int J Oncol. 26:913–921. 2005.PubMed/NCBI
37	Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. 3rd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor; NY: 1989
38	Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S, Webster TA, Harrington CA, Ho MH, Baid J, et al: Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics. 18:1593–1599. 2002. View Article : Google Scholar : PubMed/NCBI
39	Sartorius CA, Hanna CT, Gril B, Cruz H, Serkova NJ, Huber KM, Kabos P, Schedin TB, Borges VF, Steeg PS, et al: Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism. Oncogene. 10:1038–1053. 2015.
40	Wright LE, Frye JB, Lukefahr AL, Timmermann BN, Mohammad KS, Guise TA and Funk JL: Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod. 76:316–321. 2013. View Article : Google Scholar
41	Ferreira LC, Arbab AS, Jardim-Perassi BV, Borin TF, Varma NR, Iskander AS, Shankar A, Ali MM and Zuccari DA: Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer. Anticancer Agents Med Chem. 15:1285–1296. 2015. View Article : Google Scholar : PubMed/NCBI
42	Wang W, Sukamtoh E, Xiao H and Zhang G: Curcumin inhibits lymphangiogenesis in vitro and in vivo. Mol Nutr Food Res. 59:2345–2354. 2015. View Article : Google Scholar : PubMed/NCBI
43	Mohankumar K, Pajaniradje S, Sridharan S, Singh VK, Ronsard L, Banerjea AC, Benson CS, Coumar MS and Rajagopalan R: Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin - an in vitro and in silico approach. Chem Biol Interact. 210:51–63. 2014. View Article : Google Scholar
44	Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK and Maheshwari RK: Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ. 9:305–312. 1998.PubMed/NCBI
45	Mitra A, Chakrabarti J, Banerji A, Chatterjee A and Das BR: Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol. 25:679–690. 2006. View Article : Google Scholar
46	Prud'homme GJ: Cancer stem cells and novel targets for antitumor strategies. Review. Curr Pharm Des. 18:2838–2849. 2012. View Article : Google Scholar
47	Sun T, Jiang D, Zhang L, Su Q, Mao W and Jiang C: Expression profile of cathepsins indicates the potential of cathepsins B and D as prognostic factors in breast cancer patients. Oncol Lett. 11:575–583. 2016.PubMed/NCBI
48	Ruan H, Hao S, Young P and Zhang H: Targeting cathepsin B for cancer therapies. Horiz Cancer Res. 56:23–40. 2015.PubMed/NCBI
49	Chen CC, Sureshbabul M, Chen HW, Lin YS, Lee JY, Hong QS, Yang YC and Yu SL: Curcumin suppresses metastasis via Sp-1, FAK inhibition, and E-Cadherin upregulation in colorectal cancer. Evid Based Complement Alternat Med. 2013:5416952013.PubMed/NCBI